Veracyte to Participate in Three November Conferences
The cancer diagnostics company will host fireside chats at upcoming investment events in the U.S. and U.K.
Updated on Oct. 29, 2026 in Cancer
South San Francisco-based Veracyte is set to participate in three global healthcare investment conferences throughout November 2026. Company representatives will conduct fireside chats at each event to discuss their work in cancer diagnostics.
Why it matters
These sessions provide an opportunity for the public and investors to hear directly from leadership regarding the latest developments in the firm's diagnostic programs. Live webcasts will be available to broaden accessibility for those unable to attend in person.
Webcast replays of the conference presentations will be available for 90 days following each event. These materials provide a sustained window for stakeholders to review the company's diagnostic advancements.
The players
Veracyte
Veracyte is a cancer diagnostics company that provides genomic tests to help physicians better inform patient care.
The details
Veracyte, headquartered in South San Francisco, will engage with the investment community through events located in Palm Beach Gardens, London, and Nashville. Interested parties can access live audio feeds for all sessions via the company's dedicated investor website.
Timeline
The UBS Global Healthcare Conference fireside chat occurs November 10, 2026, at 4:15 p.m. ET.
The Jefferies Global Healthcare Conference fireside chat occurs November 18, 2026, at 2:30 p.m. GMT.
The Stephens Annual Investment Conference fireside chat occurs November 19, 2026, at 9:30 a.m. CT.
Health Landscape
This activity follows the established communication pattern set by the Veracyte investor events and presentations portal to provide transparency to shareholders. It mirrors broader trends in the diagnostic industry where companies utilize healthcare conferences to update the market on testing advancements.
These conferences allow the public to gain insights into how diagnostic testing technology is evolving to aid clinical decision-making. Information shared during these sessions can influence how the company prioritizes future patient-focused diagnostic research.
The takeaway
These investment events serve as a primary venue for the company to detail its diagnostic pipeline and growth strategy to a broad audience. Interested observers should check the company website to ensure they access the correct time zones for each international and domestic session.
What happens next
The company will hold a fireside chat at the UBS Global Healthcare Conference on November 10, 2026, followed by the Jefferies Global Healthcare Conference on November 18, 2026, and the Stephens Annual Investment Conference on November 19, 2026.
Further reading
For additional context on current industry developments, visit the Cancer section.
More information
You can find more details on the schedule and access the webcasts through the Veracyte investor events and presentations page.
